Screener
Wave Life Sciences WVE Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Wave Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Wave Life Sciences’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 7:50 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-324949
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Research and development | 51,293 | 43,469 | 98,733 | 84,091 |
| General and administrative | 24,781 | 17,989 | 46,884 | 36,346 |
| Total operating expenses | 76,074 | 61,458 | 145,617 | 120,437 |
| Loss from operations | (73,802) | (52,759) | (105,099) | (102,563) |
| Other income, net: | ||||
| Interest income | 4,722 | 2,372 | 10,013 | 5,247 |
| Other expense | (275) | (82) | (356) | (31) |
| Total other income, net | 4,447 | 2,290 | 9,657 | 5,216 |
Item 1. Financial Statements
FAQ
- What is Wave Life Sciences's operating income?
- Wave Life Sciences (WVE) reported operating income of -$73.8M in Q2 2026.
- How has Wave Life Sciences's operating income changed year-over-year?
- Wave Life Sciences's operating income decreased by 39.9% year-over-year, from -$52.76M to -$73.8M.
- What is the long-term trend for Wave Life Sciences's operating income?
- Over 3 years (2021 to 2025), Wave Life Sciences's operating income has grown at a 19.2% compound annual growth rate (CAGR), from -$127.02M to -$215.38M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about Wave Life Sciences's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude